Sort
11,323 grants matching “glioblastoma”
Flow Cytometry
$167,002Nancy C Van Houten · Univ Of North Carolina Chapel Hill · P30 · FY2016 · CA
PVSRIPO in melanoma
$166,997Georgia Beasley · Duke University · K08 · FY2021 · CA
Pathology and Biorepository Core (Core B)
$166,994Jason Huse · University Of Tx Md Anderson Can Ctr · P50 · FY2024 · CA
EGFR signaling network adaptations to overcome RAS-induced membrane stress in glioblastoma
$166,977Matthew J Lazzara · University Of Virginia · U54 · FY2023 · CA
A synthetic systems biology approach to predict context-specific mechanisms for SHP2 functional activity and resistance to SHP2 inhibition
$166,977Kevin A Janes · University Of Virginia · U54 · FY2023 · CA
Carbon Nanotube-based Microbeam Radiation Therapy for Human Brain Cancer
$166,846Otto Z Zhou · Univ Of North Carolina Chapel Hill · U54 · FY2014 · CA
Novel Molecular Mechanism of Glioma Pathogenesis
$166,671Suyun Huang · University Of Tx Md Anderson Can Ctr · R21 · FY2011 · CA
A clone's genomic stability as biomarker of its DNA-damage resilience
$166,644Noemi Andor · Stanford University · K99 · FY2018 · CA
A clone's genomic stability as biomarker of its DNA-damage resilience
$166,644Noemi Andor · Stanford University · K99 · FY2017 · CA
BRAIN TUMOR BIOREPOSITORY, HISTOPATHOLOGY, AND IMMUNOLOGIC MONITORING
$166,478Roger E McLendon · Duke University · P50 · FY2009 · NS
Exploiting chemoimmunotherapy strategies with genetically-engineered gd T cells
$166,413Kelly C Goldsmith · Emory University · R21 · FY2019 · CA
Open phase-separation models for cancer systems biology
$166,402Kevin A Janes · University Of Virginia · U54 · FY2023 · CA
Image Guided Genome-Epigenome Analysis of Tumor Heterogeneity and Evolution
$166,265Joseph F Costello · University Of California, San Francisco · P01 · FY2015 · CA
Core C Mouse Model Core
$166,160Alain Charest · Massachusetts General Hospital · P01 · FY2017 · CA
Core A Administration
$166,117Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2017 · CA
Nanoparticles for In Vivo Labeling of T Cells During Cancer Immunotherapy
$166,107Carlos M Rinaldi-Ramos · University Of Florida · R21 · FY2023 · CA
Flow Cytometry
$166,011Nancy C Van Houten · Univ Of North Carolina Chapel Hill · P30 · FY2017 · CA
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
$166,000Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2021 · CA
Novel, orally available ATM inhibitor for glioma conformal radiosensitization
$165,844Kristoffer Valerie · Virginia Commonwealth University · R21 · FY2017 · CA
Mechanisms regulating epithelial mesenchymal transition in development and glioma
$165,844Anjen Chenn · Northwestern University At Chicago · R21 · FY2010 · CA
Splicing factors and RNA processing alternations: exploring new players in glioblastoma development
$165,844Luiz Otavio Penalva · University Of Texas Hlth Science Center · R21 · FY2017 · CA
Identification of Long Non-coding RNAs as Novel Biomarkers for Heterogeneous Glioblastomas
$165,732Wei Zhang · Northwestern University At Chicago · R21 · FY2017 · CA
Administrative Core
$165,709John H Sampson · Duke University · P01 · FY2019 · CA
Mechanism and therapeutic potential of macrophage regulation in glioblastoma
$165,483Peiwen Chen · Northwestern University At Chicago · R00 · FY2021 · CA
Endolysosomal-nuclear communication mediated through V-ATPase and NHE9 dependent epigenetic signaling
$165,300Ronald Laribee · University Of Tennessee Health Sci Ctr · R21 · FY2019 · CA